0.84%| Prev Close: | 4.67 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 12.00 |
| Beta: | 1.75 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 2.55 - 6.25 |
| Volume: | 0 |
| Avg Vol (3m): | 230,265 |
| Market Cap: | 173.21M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.37 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare ConferencePR Newswire(Mon May 13)
- AMPIO PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Fri May 10)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri May 3)
- Ampio Pharma Initiates Phase III, Investors Extend Momentumat Seeking Alpha(Fri May 3)
- Major Pharma Companies Refocus R&D Efforts, Aim to Replace Lost Revenues: Expert Analyst Ian Somaiya Discusses M&A Drivers with The Wall Street TranscriptWall Street Transcript(Tue Apr 30)
- Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the KneePR Newswire(Thu Apr 25)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure,EDGAR Online(Thu Apr 4)
- Lucrative AMD And DME Markets Attract Wall Street To Regeneron And Other Playersat Seeking Alpha(Wed Apr 3)
- 4 Healthcare Stock Stories for Tuesday Investment Wellnessat Wall St. Cheat Sheet(Tue Apr 2)
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climbat Investor's Business Daily(Tue Apr 2)
- Ampio's Eye Drug Trial Design Won't Pass FDA Musterat TheStreet(Tue Apr 2)
- Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion™ for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun.PR Newswire(Tue Apr 2)
- Colorado stocks: Ampio up 7%; Molycorp down 5%at bizjournals.com(Thu Mar 28)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Sun Mar 17)
- AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Fri Mar 15)
Press Releases
- Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare ConferencePR Newswire(Mon May 13)
- Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the KneePR Newswire(Thu Apr 25)
- Ubika Research’s daily US Box Score: Top Junior Mining stock (OTC BB: TFER) Gained 29%Accesswire(Wed Oct 17)
Must Read
- Asian stock markets struggle to post gains as traders await signals from Federal ReserveThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Sprint receives SoftBank waiver to consider Dish offerReuters(1969-12-31T18:59:59GMT-05:00)
- When is it OK for wunderkinds to drop out of school? (Hey, it worked for Tumblr's founder!)The Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Former Montana Gov. Schweitzer elected chairman of mining company; Senate run still possibleThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Apple to argue for tax reform, defend tax practices on TuesdayReuters(1969-12-31T18:59:59GMT-05:00)